Author:
Ortega-Vázquez A,Dorado P,Fricke-Galindo I,Jung-Cook H,Monroy-Jaramillo N,Martínez-Juárez I E,Familiar-López I,Peñas-Lledó E,LLerena A,López-López M
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference56 articles.
1. Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR . Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 2010; 51: 883–890.
2. García PF, Millán R, Peñaloza Y . Epidemiología clínica de la epilepsia. Rev Mex Neuroci 2010; 11: 82–102.
3. Quet F, Preux PM, Huerta M, Ramirez R, Abad T, Fragoso G et al. Determining the burden of neurological disorders in populations living in tropical areas: who would be questioned? Lessons from a Mexican rural community. Neuroepidemiology 2011; 36: 194–203.
4. Martínez-Juárez IE, López-Zapata R, Gómez-Arias B, Bravo-Armenta E, Romero-Ocampo L, Estévez-Cruz Z et al. Epilepsia farmacorresistente: uso de la nueva definición y factores de riesgo relacionados. Estudio en población mexicana de un centro de tercer nivel. Rev Neurol 2012; 54: 159–166.
5. Thorn CF, Whirl-Carrillo M, Leeder JS, Klein TE, Altman RB . PharmGKB summary: phenytoin pathway. Pharmacogenet Genomics 2012; 22: 466–470.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献